Facebook Pixel Code

Biocon Share Price

NSE
BSE
FUT
OPT

BIOCON

Largecap | BSE

Here's the live share price of Biocon along with daily highs, lows, percentage changes and volume trends, and, all financial information.

₹385.00 Closed
-1.96₹ -7.70
As on Mar 13, 2026, 4:01 PM IST
Intraday
1W
1M
3M
6M
YTD
1Y
3Y
5Y
10Y

Biocon Price Performance

Today's LowToday's High
₹382.35₹398.65
₹385.00
52 Weeks' Low52 Weeks' High
₹295.30₹424.95
₹385.00
Open Price
₹394.75
Prev. Close
₹392.70
Volume
5,70,546

Over the last 5 years, the share price of Biocon has declined 0.54% CAGR. Over the past year, the corresponding return has been 19.23%.

Biocon’s current P/E of 103.29x helps give context to how the market is valuing the stock based on recent earnings and growth expectations.

Biocon Peer Comparision

Stock Performance
Ratio Performance
Name
1W(%)
1M(%)
3M(%)
6M(%)
1Y(%)
3Y(%)
5Y(%)
Biocon
-1.401.91-1.427.4119.2320.83-0.54
Sun Pharmaceutical Industries
0.096.030.1812.366.9323.5724.36
Divi's Laboratories
-4.15-1.69-4.440.217.9229.8812.20
Torrent Pharmaceuticals
1.837.6816.0224.2043.4342.7729.25
Dr. Reddy's Laboratories
-1.191.640.62-0.9616.3013.698.21
Cipla
-0.58-1.26-12.81-15.10-10.0914.5110.29
Lupin
-1.265.2610.7513.0917.5652.3716.88
Zydus Lifesciences
-0.800.09-1.69-12.642.6224.8415.54
Mankind Pharma
-2.233.75-0.24-17.26-2.8814.508.46
Aurobindo Pharma
5.2512.869.3417.9818.4142.469.20
Alkem Laboratories
-3.51-1.04-4.83-2.8113.6320.3214.77
Glenmark Pharmaceuticals
2.468.919.523.5954.8472.2335.65
Abbott India
-1.401.86-3.34-12.81-8.9410.0913.16
Laurus Labs
-2.29-0.81-0.2312.0874.7348.8422.92
GlaxoSmithKline Pharmaceuticals
-3.55-6.57-5.88-12.03-8.8023.1811.12
Ipca Laboratories
4.714.858.2819.1320.2025.3810.22
Ajanta Pharma
1.043.5314.5118.5318.9235.3319.95
Anthem Biosciences
-3.18-7.08-8.42-23.33-12.37-4.31-2.61
J B Chemicals & Pharmaceuticals
3.4412.1018.3926.3839.7829.5528.72
Emcure Pharmaceuticals
1.46-3.572.796.1654.961.851.10

Over the last one year, Biocon has gained 19.23% compared to peers like Sun Pharmaceutical Industries (6.93%), Divi's Laboratories (7.92%), Torrent Pharmaceuticals (43.43%). From a 5 year perspective, Biocon has underperformed peers relative to Sun Pharmaceutical Industries (24.36%) and Divi's Laboratories (12.20%).

Biocon Financials

Consolidated
Standalone
Quarterly P&L
Annual P&L
Balance Sheet
Cash Flow
Income Statement
Ratios

Biocon Stock Technicals

Moving Average

DaySMAEMA
5391.57392.42
10390.39390.41
20385.78386.85
50379.59383
100383.83379.85
200372.06372.11

Biocon Share Holding Pattern

In the latest quarter, Biocon saw a drop in promoter holding to 44.92%, while DII stake increased to 24.16%, FII holding rose to 7.14%, and public shareholding moved down to 23.69% compared to the previous quarter — reflecting a shift in investor sentiment across categories.

Biocon Stock Mutual Fund Holdings

Fund Name
No. Of Shares
% of AUM
Amount Invested(in ₹ crore)
4,00,73,9253.021,469.91
1,55,98,5842.55572.16
1,30,00,0001.59476.84
1,20,44,7371.18441.8
1,02,45,6400.93375.81
97,73,3141.56358.49
69,86,2531.11256.26
60,45,4761.47228.49
60,26,8950.45221.07
58,06,2952.51212.97

* Excluding Index & Arbitrage Funds

View All Mutual Funds

Biocon Futures

Price
  (%)
As on Invalid Date IST
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Biocon Options

Price
  (%)
Not traded today
Open Interest
  (%)
High
Low
Open
Close
Contract Traded
Turnover (in lakhs)

Biocon Corporate Actions

Date Time
Announcement
Mar 13, 2026, 2:40 AM ISTBiocon - Notification To Stock Exchanges
Mar 05, 2026, 9:21 PM ISTBiocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Mar 04, 2026, 4:35 AM ISTBiocon - Announcement under Regulation 30 (LODR)-Acquisition
Mar 02, 2026, 10:23 PM ISTBiocon - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Feb 25, 2026, 12:07 PM ISTBiocon - Announcement under Regulation 30 (LODR)-Investor Presentation

About Biocon

Biocon Ltd. is a Public Limited Listed company incorporated on 29/11/1978 and has its registered office in the State of Karnataka, India. Company's Corporate Identification Number(CIN) is L24234KA1978PLC003417 and registration number is 003417. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 2242.60 Cr. and Equity Capital is Rs. 600.30 Cr. for the Year ended 31/03/2025.

Management

  • Ms. Kiran Mazumdar Shaw
    Executive Chairperson
  • Mr. Siddharth Mittal
    Managing Director & CEO
  • Prof. Ravi Rasendra Mazumdar
    Non Exe.Non Ind.Director
  • Mr. Eric Vivek Mazumdar
    Non Exe.Non Ind.Director
  • Mr. Bobby Kanubhai Parikh
    Independent Director
  • Mr. Naina Lal Kidwai
    Lead Independent Director
  • Ms. Rekha Mehrotra Menon
    Independent Director
  • Mr. Nicholas Robert Haggar
    Independent Director
  • Mr. Atul Dhawan
    Independent Director

FAQs on Biocon Share Price

What is the share price of Biocon?

The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Biocon is ₹385.00 as on Mar 13, 2026.

What kind of stock is Biocon?

The Biocon is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.

What is the Market Cap of Biocon?

The market cap of Biocon is ₹62,404.95 Cr as on Mar 13, 2026.

What are today's High and Low prices of Biocon?

Today’s highest and lowest price of Biocon are ₹398.65 and ₹382.35.

What are the 52 Week High and 52 Week Low of Biocon?

The 52-week high/low is the highest and lowest price at which Biocon stock has traded in the past 52-week or nearly a year. The 52-week high of Biocon is ₹424.95 and 52-week low of Biocon is ₹295.30 as on Mar 13, 2026.

How has the Biocon performed historically in terms of returns?

The Biocon has shown returns of -1.96% over the past day, 1.91% for the past month, -1.42% over 3 months, 19.23% over 1 year, 20.83% across 3 years, and -0.54% over 5 years.

What are the P/E ratio, dividend yield and PB ratio of Biocon?

P/E ratio of and PB ratio of Biocon are 103.29 and 2.32 on Mar 13, 2026. While the company gives a dividend yield of 0.13 per annum.

icon
Market Pulse